12.07.2015 Views

Nutrition in pediatric cardiomyopathy - Children's Cardiomyopathy ...

Nutrition in pediatric cardiomyopathy - Children's Cardiomyopathy ...

Nutrition in pediatric cardiomyopathy - Children's Cardiomyopathy ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

68 T.L. Miller et al. / Progress <strong>in</strong> Pediatric Cardiology 24 (2007) 59–71failure generally exhibit a marked depletion (up to 50%) of bothfree and total carnit<strong>in</strong>e [89. 92]. L-Carnit<strong>in</strong>e supplementation[89,92,93] can result <strong>in</strong> overall improvement <strong>in</strong> the cardiac statusand quality of life of both animals and patients with myocardialdysfunction. A multicentered, randomized, placebo-controlled,double-bl<strong>in</strong>d cl<strong>in</strong>ical trial [94] showed a significant beneficialeffect, <strong>in</strong>clud<strong>in</strong>g a reduction <strong>in</strong> adverse cardiac remodel<strong>in</strong>g, whenL-carnit<strong>in</strong>e was taken for 12 months after myocardial <strong>in</strong>farction.Furthermore, improved 3 year survival was also found <strong>in</strong> patientsgiven daily doses of L-carnit<strong>in</strong>e [95]. Similar to other nutrients, itis clear that more studies will be needed to determ<strong>in</strong>e the potentialbenefits of this nutrient. Furthermore, there cont<strong>in</strong>ues to be adearth of studies <strong>in</strong> the <strong>pediatric</strong> population with heart failure.3.4.3. Creat<strong>in</strong>eCreat<strong>in</strong>e phosphate is the substrate for phosphate transfer toADP to form ATP by the enzymatic activity of creat<strong>in</strong>e k<strong>in</strong>ase.Creat<strong>in</strong>e is synthesized <strong>in</strong> the liver and spleen from arg<strong>in</strong><strong>in</strong>e,glyc<strong>in</strong>e and methion<strong>in</strong>e. The concentration of creat<strong>in</strong>e <strong>in</strong> themyocardiocyte is determ<strong>in</strong>ed by adrenergic drive [96], thus withheart failure, the concentration of creat<strong>in</strong>e <strong>in</strong> the cell may bedim<strong>in</strong>ished [96,97]. Creat<strong>in</strong>e can improve calcium homeostasis[98] and survival of myocytes <strong>in</strong> culture.Creat<strong>in</strong>e supplements <strong>in</strong>creases skeletal muscle creat<strong>in</strong>e, andthis may be most beneficial dur<strong>in</strong>g short-term exercise to improvemuscle strength, endurance and metabolism by reduc<strong>in</strong>g lactate[99–101]. Thus, creat<strong>in</strong>e supplementation may not be as beneficialunder normal situations. There have been few, if any studies oncreat<strong>in</strong>e's effects on heart failure, with notably none <strong>in</strong> children.3.5. Other nutrients3.5.1. Vitam<strong>in</strong> D/calciumAdequate <strong>in</strong>take (Table 1) of calcium and vitam<strong>in</strong> D needs tobe <strong>in</strong>sured, as these nutrients are critical to optimize cardiacfunction. The childhood diet is typically deficient <strong>in</strong> both ofthese nutrients with <strong>in</strong>takes of only 50% of the DRI widelyreported. In animal models, rats fed a vitam<strong>in</strong> D deficient dietdeveloped poor cardiac function that was reversed withsupplementation of vitam<strong>in</strong> D [102].3.5.2. Folate/vitam<strong>in</strong> B12Folate is required to convert homocyste<strong>in</strong>e to methione.Folate deficiency is frequently detected <strong>in</strong> patients with heartfailure [103] and often this is co<strong>in</strong>cident with low folate dietary<strong>in</strong>take [104]. Vascular endothelial function may be improved byfolate [105]. Similarly, vitam<strong>in</strong> B12 deficiency is also l<strong>in</strong>ked tohigher homocyste<strong>in</strong>e levels. However, studies show that neitherfolate nor vitam<strong>in</strong> B12 improves <strong>in</strong>tr<strong>in</strong>sic cardiac function, yetthere may be greater effects on peripheral vasculature [106].3.5.3. MagnesiumMagnesium deficiency can occur <strong>in</strong> up to 30% of patients withheart failure [107–109]. Medications, such as loop and thiazidediuretics contribute to ur<strong>in</strong>ary magnesium loss. Magnesiumdeficiency is associated with sodium retention and <strong>in</strong>creasedventricular ectopy [110–112] with associated reduced cardiaccontractility and <strong>in</strong>creased peripheral vascular resistance[113,114].3.5.4. Z<strong>in</strong>cZ<strong>in</strong>c is a trace m<strong>in</strong>eral that is required for proper function ofone of the antioxidant enzyme systems and its deficiency isrelated to apoptosis of the myocardiocyte [115]. Severalmedic<strong>in</strong>es <strong>in</strong>clud<strong>in</strong>g angiotens<strong>in</strong> convert<strong>in</strong>g enzyme <strong>in</strong>hibitors,angiotens<strong>in</strong> II antagonists and thiazide diuretics can <strong>in</strong>creaseur<strong>in</strong>ary z<strong>in</strong>c [116,117]. However, it is unclear if z<strong>in</strong>c deficiencyis related to or can improve heart failure.3.5.5. SeleniumSelenium is a trace m<strong>in</strong>eral that can be found <strong>in</strong> smallamounts <strong>in</strong> the soil and food. Depend<strong>in</strong>g on the region of theworld, foods grown <strong>in</strong> certa<strong>in</strong> areas may have sufficient or poorconcentrations of selenium ow<strong>in</strong>g to soil content. Meat andseafood have the greatest concentrations of selenium. Seleniumdeficiency has been associated with congestive <strong>cardiomyopathy</strong>(Keshan disease), skeletal myopathy, osteoarthropathy (Kash<strong>in</strong>–Beck disease), anemia, immune system alterations, <strong>in</strong>creasedrisk of cancer, cardiovascular disease, hair and nail changes,<strong>in</strong>fertility, and abnormalities <strong>in</strong> thyroid hormone metabolism <strong>in</strong>humans [118]. Selenium's greatest role is its action as a cofactorfor the antioxidant enzyme, glutathione peroxidase whichremoves hydrogen peroxide and the deleterious lipid hydroperoxidesgenerated by oxygen-derived species. Glutathioneperoxidase deficiency contributes to endothelial dysfunction amajor contribut<strong>in</strong>g factor <strong>in</strong> heart failure [119], <strong>in</strong> variousconditions such as hyperhomocyste<strong>in</strong>emia [120]. This suggeststhat homocyste<strong>in</strong>e may be <strong>in</strong>volved <strong>in</strong> heart failure associatedendothelial dysfunction through a peroxide-dependent oxidativemechanism. Selenium also plays a role <strong>in</strong> the control of thyroidhormone metabolism [121] by affect<strong>in</strong>g synthesis and activity ofde-iod<strong>in</strong>ases, enzymes convert<strong>in</strong>g thyrox<strong>in</strong> <strong>in</strong>to the biologicallyactive triiodothyron<strong>in</strong>e [122]. Thus, selenium (through its role <strong>in</strong>selenoenzymes, thyroid hormones, and <strong>in</strong>teractions with homocyste<strong>in</strong>eand endothelial function) appears to be a majormediator <strong>in</strong> several pathways potentially contribut<strong>in</strong>g to orpossibly prevent<strong>in</strong>g heart failure.The first case of endemic selenium deficiency was described<strong>in</strong> 1935 <strong>in</strong> Keshan County, <strong>in</strong> Ch<strong>in</strong>a. Cl<strong>in</strong>ical features were acuteand/or chronic episodes of cardiogenic shock and/or congestiveheart failure. Selenium supplementation may stop progression ofthe cardiac disease but is less successful at revers<strong>in</strong>g the exist<strong>in</strong>gcardiac damage [123]. The daily recommended <strong>in</strong>take ofselenium is 20–55 μg/day, depend<strong>in</strong>g on the age of the child.(30) (Table 1). Selenium deficiency <strong>in</strong> developed nations is moreoften seen <strong>in</strong> chronically ill, malnourished patients withmalabsorption and <strong>in</strong> unsupplemented total parenteral nutrition(TPN)-dependent patients [124,125]. Selenium deficiency alsois encountered when nutrient-limited diets are used such aspatients with phenylketonuria [126] and the ketogenic diet.Assessment of selenium status is difficult because no optimalmethod is known. Dietary assessment is <strong>in</strong>accurate, andselenium content depends on where the food was grown (soilcontent), which is usually unknown. Selenium can be measured

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!